fludarabine and entinostat

fludarabine has been researched along with entinostat in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acharya, MR; Figg, WD1
Chen, B; Fang, Q; He, Z; Li, P; Ma, D; Ren, M; Wang, J; Zhe, N; Zhong, Q; Zhou, Z1

Other Studies

2 other study(ies) available for fludarabine and entinostat

ArticleYear
Histone deacetylase inhibitor enhances the anti-leukemic activity of an established nucleoside analogue.
    Cancer biology & therapy, 2004, Volume: 3, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; Cell Cycle; Cell Cycle Proteins; DNA (Cytosine-5-)-Methyltransferases; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Humans; Leukemia; Pyridines; Reactive Oxygen Species; Vidarabine

2004
Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
    Life sciences, 2019, Sep-01, Volume: 232

    Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Benzamides; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Female; Heme Oxygenase-1; Histone Deacetylase 1; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Nude; Middle Aged; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-bcl-2; Pyridines; Random Allocation; Signal Transduction; Tumor Suppressor Protein p53; Vidarabine; Xenograft Model Antitumor Assays

2019